Literature DB >> 16550595

Trends in survival and excess risk of death after diagnosis of cancer in 1980-1996 in New South Wales, Australia.

Xue Q Yu1, Dianne L O'Connell, Robert W Gibberd, Alan S Coates, Bruce K Armstrong.   

Abstract

Survival from almost all cancers has improved during the last 30 years. There is debate over the reasons for the improvement. We examined trends in survival for 28 cancers from 1980 to 1996 in New South Wales (NSW), Australia, with adjustment for disease spread at diagnosis. NSW Central Cancer Registry data were used to estimate 5-year relative survival and relative excess risk of death for patients diagnosed in 1980-84, 1985-88, 1989-92 and 1993-96. Statistical significance of variation in excess deaths between periods of diagnosis was assessed using Poisson regression, with adjustment for age, sex, duration of follow-up, histology and spread of disease at diagnosis. There were statistically significant falls in excess deaths for 20 of the cancers with a 25% fall for all cancers combined. Cancers of the prostate, liver, thyroid, breast, gallbladder, body of uterus, rectum, cervix and ovary had falls of >30%. The falls varied by spread of disease; the largest being in localised and regionally spread tumours. Overall survival, when unadjusted for spread of cancer, generally fell in parallel with that in the specific categories of spread, which implies that stage migration did not contribute importantly to survival trends. While acknowledging the limitations of incomplete data on stage of cancer at diagnosis, we conclude that falls in excess deaths in NSW from 1980 to 1996 are unlikely, for many cancers, to be attributed to earlier diagnosis or stage migration; thus advances in cancer treatment have almost certainly contributed to them. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16550595     DOI: 10.1002/ijc.21909

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  Survival after a diagnosis of testicular germ cell cancers in Germany and the United States, 2002-2006: a high resolution study by histology and age.

Authors:  A Stang; L Jansen; B Trabert; C Rusner; A Eberle; A Katalinic; K Emrich; B Holleczek; H Brenner
Journal:  Cancer Epidemiol       Date:  2013-04-23       Impact factor: 2.984

2.  Improved survival for non-Hodgkin lymphoma patients in New South Wales, Australia.

Authors:  Xue Q Yu; Wendy H Chen; Dianne L O'Connell
Journal:  BMC Cancer       Date:  2010-05-24       Impact factor: 4.430

3.  An initial melanoma diagnosis may increase the subsequent risk of prostate cancer: Results from the New South Wales Cancer Registry.

Authors:  D Cole-Clark; V Nair-Shalliker; A Bang; K Rasiah; V Chalasani; D P Smith
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

4.  Widening socioeconomic disparity in lung cancer incidence among men in New South Wales, Australia, 1987-2011.

Authors:  Xue Qin Yu; Qingwei Luo; Clare Kahn; Camilla Cahill; Marianne Weber; Paul Grogan; Ahmedin Jemal; Dianne L O'Connell
Journal:  Chin J Cancer Res       Date:  2017-10       Impact factor: 5.087

5.  Crude probability of death for cancer patients by spread of disease in New South Wales, Australia 1985 to 2014.

Authors:  Xue Qin Yu; Paramita Dasgupta; Clare Kahn; Kou Kou; Susanna Cramb; Peter Baade
Journal:  Cancer Med       Date:  2021-05-06       Impact factor: 4.452

6.  Projecting prevalence by stage of care for prostate cancer and estimating future health service needs: protocol for a modelling study.

Authors:  Xue Q Yu; David P Smith; Mark S Clements; Manish I Patel; Bill McHugh; Dianne L O'Connell
Journal:  BMJ Open       Date:  2011-04-07       Impact factor: 2.692

7.  Cancer-related hospitalisations and 'unknown' stage prostate cancer: a population-based record linkage study.

Authors:  Qingwei Luo; Xue Qin Yu; David Paul Smith; David Eamon Goldsbury; Claire Cooke-Yarborough; Manish Indravadan Patel; Dianne Lesley O'Connell
Journal:  BMJ Open       Date:  2017-01-11       Impact factor: 2.692

8.  Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis.

Authors:  Wahyu Wulaningsih; Mariam Vahdaninia; Mark Rowley; Lars Holmberg; Hans Garmo; Håkan Malmstrom; Mats Lambe; Niklas Hammar; Göran Walldius; Ingmar Jungner; Anthonius C Coolen; Mieke Van Hemelrijck
Journal:  BMC Cancer       Date:  2015-11-17       Impact factor: 4.430

9.  A population-based study of breast cancer prevalence in Australia: predicting the future health care needs of women living with breast cancer.

Authors:  Xue Qin Yu; Roberta De Angelis; Qingwei Luo; Clare Kahn; Nehmat Houssami; Dianne L O'Connell
Journal:  BMC Cancer       Date:  2014-12-11       Impact factor: 4.430

10.  Cancer survival in New South Wales, Australia: socioeconomic disparities remain despite overall improvements.

Authors:  Julia F Stanbury; Peter D Baade; Yan Yu; Xue Qin Yu
Journal:  BMC Cancer       Date:  2016-02-01       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.